retatrutide weight loss study Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Lilly's triple agonist, retatrutide, delivered

They found that it significantly attenuated the blood glucose levels and enhanced the in vivo antioxidants, increasing the serum glutathione levels, which is critical in protecting cells from oxidative damage caused by free radicals [76]

Retatrutide represents a novel class of medication known as a triple incretin receptor agonist

While many interventions for AD/ADRD have focused on midlife and late-life deficits, a precision brain health approach to AD/ADRD prevention should consider opportunities for personalized interventions implemented at earlier ages as part of a life-course approach to brain health optimization and resilience

This information should be interpreted with a qualified healthcare provider as part of a broader assessment

You dont need to hit the gym

Step 2: Clinician review